These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
381 related items for PubMed ID: 24708193
21. [Clinical value of FDG PET using coincident gamma cameras in staging and restaging of malignant lymphoma--compared with convenitonal diagnostic methods]. Pichler R, Maschek W, Hatzl-Griesenhofer M, Huber H, Wimmer G, Wahl G, Fridrik M. Nuklearmedizin; 2000 Sep; 39(6):166-73. PubMed ID: 11057408 [Abstract] [Full Text] [Related]
22. Early detection of relapse by whole-body positron emission tomography in the follow-up of patients with Hodgkin's disease. Jerusalem G, Beguin Y, Fassotte MF, Belhocine T, Hustinx R, Rigo P, Fillet G. Ann Oncol; 2003 Jan; 14(1):123-30. PubMed ID: 12488304 [Abstract] [Full Text] [Related]
24. Lymphoma: role of whole-body 2-deoxy-2-[F-18]fluoro-D-glucose (FDG) PET in nodal staging. Moog F, Bangerter M, Diederichs CG, Guhlmann A, Kotzerke J, Merkle E, Kolokythas O, Herrmann F, Reske SN. Radiology; 1997 Jun; 203(3):795-800. PubMed ID: 9169707 [Abstract] [Full Text] [Related]
28. Role of routine imaging in detecting recurrent lymphoma: A review of 258 patients with relapsed aggressive non-Hodgkin and Hodgkin lymphoma. El-Galaly TC, Mylam KJ, Bøgsted M, Brown P, Rossing M, Gang AO, Haglund A, Arboe B, Clausen MR, Jensen P, Pedersen M, Bukh A, Jensen BA, Poulsen CB, d'Amore F, Hutchings M. Am J Hematol; 2014 Jun; 89(6):575-80. PubMed ID: 24493389 [Abstract] [Full Text] [Related]
29. Computed tomography and positron emission tomography/computed tomography surveillance after combined modality treatment of supradiaphragmatic Hodgkin lymphoma: a clinical and economic perspective. Patel V, Buckstein M, Perini R, Hill-Kayser C, Svoboda J, Plastaras JP. Leuk Lymphoma; 2013 Oct; 54(10):2168-76. PubMed ID: 23331161 [Abstract] [Full Text] [Related]
30. Assessment of tumor recurrence in patients with colorectal cancer and elevated carcinoembryonic antigen level: FDG PET/CT versus contrast-enhanced 64-MDCT of the chest and abdomen. Metser U, You J, McSweeney S, Freeman M, Hendler A. AJR Am J Roentgenol; 2010 Mar; 194(3):766-71. PubMed ID: 20173157 [Abstract] [Full Text] [Related]
33. FDG-PET/CT in re-staging of patients with lymphoma. Freudenberg LS, Antoch G, Schütt P, Beyer T, Jentzen W, Müller SP, Görges R, Nowrousian MR, Bockisch A, Debatin JF. Eur J Nucl Med Mol Imaging; 2004 Mar; 31(3):325-9. PubMed ID: 14647988 [Abstract] [Full Text] [Related]
34. Limited utility of routine surveillance imaging for classical Hodgkin lymphoma patients in first complete remission. Pingali SR, Jewell SW, Havlat L, Bast MA, Thompson JR, Eastwood DC, Bartlett NL, Armitage JO, Wagner-Johnston ND, Vose JM, Fenske TS. Cancer; 2014 Jul 15; 120(14):2122-9. PubMed ID: 24711253 [Abstract] [Full Text] [Related]
35. Diagnosis of metastases from postoperative differentiated thyroid cancer: comparison between FDG and FLT PET/CT studies. Nakajo M, Nakajo M, Jinguji M, Tani A, Kajiya Y, Tanabe H, Fukukura Y, Nakabeppu Y, Koriyama C. Radiology; 2013 Jun 15; 267(3):891-901. PubMed ID: 23468571 [Abstract] [Full Text] [Related]
36. [18-FDG-PET-findings in children and adolescents with Hodgkin's disease: retrospective evaluation of the correlation to other imaging procedures in initial staging and to the predictive value of follow up examinations]. Wickmann L, Lüders H, Dörffel W. Klin Padiatr; 2003 Jun 15; 215(3):146-50. PubMed ID: 12778354 [Abstract] [Full Text] [Related]
38. Fused FDG-PET/contrast-enhanced CT detects occult subdiaphragmatic involvement of Hodgkin's lymphoma thereby identifying patients requiring six cycles of anthracycline-containing chemotherapy and consolidation radiation of spleen. Picardi M, Soricelli A, Grimaldi F, Nicolai E, Gallamini A, Pane F. Ann Oncol; 2011 Mar 15; 22(3):671-680. PubMed ID: 20693297 [Abstract] [Full Text] [Related]
39. Hodgkin lymphoma patients in first remission: routine positron emission tomography/computerized tomography imaging is not superior to clinical follow-up for patients with no residual mass. Dann EJ, Berkahn L, Mashiach T, Frumer M, Agur A, McDiarmid B, Bar-Shalom R, Paltiel O, Goldschmidt N. Br J Haematol; 2014 Mar 15; 164(5):694-700. PubMed ID: 24313286 [Abstract] [Full Text] [Related]